Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SPPL2C | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | CCP110 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | TGFBR1 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | KIAA1614 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | DOK6 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | IL3RA | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | ZNF618 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
mRNA | SRRM3 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | PHF10 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | ZNF704 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |